Oh and I have £40k banked on SNG and a free carry for my remaining stock but hey, don’t let the truth get in the way of a hackneyed story! |
And just a further fact to put a massive whole in your hackneyed argument is my wife is non stipendary. She effectively does the job for free… |
Where did that hate filled post come from?!? Dear oh dear….I despair of this BB |
nobbygnome - either that or they'll tap up long-suffering shareholders. |
So who is going to pay for this trial as IMM certainly don’t have sufficient funds. Presumably they are talking to partners?!? |
The uptick is down to this morning's RNS. |
Some support with buying on the up. Does anyone know if there is any positive news on the way? |
Well they used much higher doses in animal models which worked. From memory Muller was talking about the human clinical data and my information was there was a problem with the 1000 ug dose which allegedly precipitated when injected. So if true, no doubt that is the reason why the higher dose didn’t work…. |
Well if you look back several years Professor Muller stated threat in the tests higher doses showed less efficacy |
So IV not SC in the new study because they need to get multiples higher of the blood concentration. That has been my mantra all the way through but I have to admit I’m surprised they have felt the need to go IV. That makes the drug less usable and less tolerable for patients so is a big negative in my book. Why not go for multiple injections if they can’t get the concentration high enough in the syringe.
Anyway the bottom line is they would have saved themselves many years of wasted time if they had listened to me…. |
Out of the SVB mess
those companies that are strong with an ' in demand' product will triumph
Keep an eye on the light at the end of this SVB saga Tunnel.
The strong will survive and thrive ! |
johneee - the latter methinks. At least until we’ve significant further news on trial timelines. |
has this hit the bottom and ready to explode upwards?
Or languishing for a while......gathering dust? |
Bobby knows his onions and knows the price history of this fiasco. I met Tim back in the day who was super confident and f all materialised... |
Nobs-fed up with your constant negative attitude. Obviously this is a punt rather than an investment. Clearly there is a very significant risk that any money gambled will be totally lost. However, at these levels the upside could be huge from say-5 to 20 bagger or more.
All we can do is wait and see-3 years is not a long time scale to wait for that sort of return.
That's all-more next year! |
If you think 3 years is close then yeah… |
Any drug development takes time.
All hangs on Global partners helping to smooth the road to rollout
After all this work
Immupharma is the closest it has ever been to glory--Hang on in there |
The Drug is on fast status approval so Stage two is linked to stage 3. |
How long phase 2 will take... |
3 years???? |
Have to Say Nobbygnome pointed at several unknowns and facts regarding IMM on the trail , for myself well down on but 50% but was speculative and always will be.
In the end 1 year to 3 years if approved looking at 1000% gain , will that happen maybe or not.
Then other stocks invested have gained ten fold which on balance is as a whole positive in investing in stocks.
High Risk - high rewards - High Risk - Loss of investment nearly
This is not a day traders investment |
Good point. Avion were sold a turkey although of course they didn’t pay anything up front for that reason. Nevertheless they must already have spent quite a lot on consultants and the bill for the trial just went up substantially from what they expected! |
Register to chat with like-minded investors on our interactive forums.
Hot Features
Premium
